Dr. Stanley Obinna Ikezi, M.D. Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1534 Park Ave, Suite 310, Quakertown, PA 18951 Phone: 215-538-6430 Fax: 215-893-7098 |
Scott Jeffrey Loev, DO Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1534 Park Ave, Suite 310, Quakertown, PA 18951 Phone: 215-538-6430 Fax: 484-893-7098 |
Dr. Rammurti Anthony Mckenzie, M.D. Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1534 Park Ave Ste 310, Quakertown, PA 18951 Phone: 484-526-7246 Fax: 866-291-6192 |
Dr. Farooq A Qureshi, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1534 Park Ave, Suite 310, Quakertown, PA 18951 Phone: 215-538-6430 Fax: 215-536-3258 |
Joshua Michael Wert, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1534 Park Ave, Suite 310, Quakertown, PA 18951 Phone: 215-538-6430 Fax: 484-893-7098 |
News Archive
More than a third of young adults report using both cannabis and tobacco or nicotine products, providing a unique challenge to public health officials as cannabis is legalized in more jurisdictions, according to a new RAND Corporation study.
Biotechnology company Arana Therapeutics Limited today announced that lead anti-inflammatory compound, ART621 has successfully passed review of its rheumatoid arthritis Investigational New Drug (IND) application by the US Food and Drug Administration (FDA).
The lab of Kevin Foskett, PhD, the Isaac Ott Professor of Physiology at the University of Pennsylvania School of Medicine, has found a possible new target for fighting cystic fibrosis (CF) that could compensate for the lack of a functioning ion channel in affected CF-related cells. Their finding appears in the Journal of Clinical Investigation.
Disorders of consciousness such as coma or a vegetative state caused by severe brain injury are poorly understood and their diagnosis has relied mainly on patient responses and measures of brain activity. However, new functional and imaging-based diagnostic tests that measure communication and signaling between different brain regions may provide valuable information about the potential for consciousness in patients unable to communicate. These innovative approaches are described and compared in a Review article in the groundbreaking neuroscience journal Brain Connectivity, a bimonthly peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
GenoMed announced today that the Company has submitted its 50th provisional patent application, a major milestone in any development stage company. GenoMed has so far been awarded two patents, one for treating acute kidney failure without dialysis, and another for hastening lung maturation in prematurely born infants.
› Verified 1 days ago